SCHEMBL7826679

SCHEMBL7826679

Cc1oc2c(NC(=O)c3c(F)cccc3Cl)cccc2c1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
MAPT P10636 4/20 0.48
GAA P10253 4/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
JAK2 O60674 1/20 0.47
JAK1 P23458 1/20 0.47
TYK2 P29597 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TP53 P04637 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
TAS1R2 Q8TE23 1/20 0.44
TLR7 Q9NYK1 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
POLB P06746 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7823933 0.91 MAPT (0.48) MAPTRAB9ANPSR1JAK2JAK1
SCHEMBL7826791 0.87 MAPT (0.44) MAPTRAB9ANPSR1MEN1KMT2A
SCHEMBL7831960 0.84 GPR35 (0.43) MAPTNPSR1MEN1KMT2AKDM4E
SCHEMBL7825581 0.84 MAPT (0.41) MAPTRAB9ANPSR1MEN1KMT2A
SCHEMBL7831446 0.83 MAPT (0.41) MAPTRAB9ANPSR1MEN1KMT2A
SCHEMBL7832094 0.83 ALDH1A1 (0.40) MAPTRAB9ANPSR1MEN1KMT2A
SCHEMBL7827801 0.83 MAPT (0.42) MAPTRAB9ANPSR1KDM4EALDH1A1
SCHEMBL7831953 0.83 ALDH1A1 (0.46) L3MBTL1MAPTRAB9ANPSR1MEN1
SCHEMBL7827661 0.82 TP53 (0.43) MAPTRAB9ANPSR1TP53TAS1R3
SCHEMBL7815986 0.81 MAPT (0.39) MAPTRAB9ANPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757682-B1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO (JP) 2001-06-20 EP disclosed
US-5858995-A ADMINISTERING TO HUMANS AND ANIMALS IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL BONE METABOLISM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-01-12 US disclosed